Revolution Medicines, Inc. files DEFA14A

Here is a summary of the SEC proxy filing for an investor: This filing concerns Revolution Medicines, Inc.'s Annual Meeting of Stockholders on June 18, 2026, where shareholders will vote on director elections, auditor ratification, and executive compensation. The Board of Directors recommends voting FOR all proposals.